BACKGROUND The Red Blood Cell (RBC)‐Omics study was initiated to build a large data
set containing behavioral, genetic, and biochemical characteristics of blood donors with …

Nucleic acid–based technology is now at a point where the field of transfusion medicine is
ready for its widespread application. In the donor center, genotyping of red blood cell (RBC) …

Background The use of omics technologies in human transfusion medicine has improved
our understanding of the red blood cell (RBC) storage lesion (s). Despite significant …

Erythrocyte concentrates for transfusion purposes represent a life-saving therapeutics of
primary relevance in the clinical setting. However, efforts have been continuously proposed …

Red blood cell storage in the blood bank makes millions of units of available for transfusion
to civilian and military recipients every year. From glass bottles to plastic bags, from …

BACKGROUND The transfusion of red blood cells (RBCs) with maximum therapeutic
efficacy is a major goal in transfusion medicine. One of the criteria used in determining …

Population-based investigations suggest that red blood cells (RBCs) are therapeutically
effective when collected, processed, and stored for up to 42 days under validated conditions …

Background: The key advantages of latest third-generation long-read sequencing (TGS)
technologies include the ability to resolve long haplotypes and to characterize genomic …

The field of transfusion medicine is on the threshold of a paradigm shift, as the technology
for genotyping of red blood cell antigens, including US FDA-approved arrays, is now moving …

Background While blood transfusion is an essential cornerstone of hematological care,
patients requiring repetitive transfusion remain at persistent risk of alloimmunization due to …